Dear members, please let me have any feedback at regulatory@bivda.org.uk regarding the below update from MedTech Europe on the inclusion of MCCP to the UN Convention and EU POPs legislation. In principle I’m happy to support the MedTech Europe position re: MCCP
We are writing to invite you to share input by 9 January 2026 EOB to an action from the Secretariat of the Stockholm Convention asking to provide information on the ‘best available techniques’ in handling POPs that were recently added to the Convention, namely Chlorpyrifos, Long Chain PFCAs, and MCCP.
Background:
- At its twelfth meeting held in April/May 2025, in decision SC-12/5, the Conference of the Parties (COP) to the Stockholm Convention agreed to the workplan for the ongoing review and updating of the guidelines and guidance on best available techniques and best environmental practices (document UNEP/POPS/COP.12/8/Rev.1, annex II).
- The COP also agreed to invite Parties and Observers (such as MedTech Europe) to contribute to the further review and update of the guidelines and guidance by submitting information on the successful application of best available techniques (BAT) and best environmental practices (BEP) relevant to the chemicals listed in Annexes A, B, and C to the Convention and other technical information.
- Further information on BAT and BEP is available at the link here.
Action by 9 January 2026 EOB:
We are now given the possibility until 31 January 2026 to do the following 2 actions:
- Request to participate in this workstream in the coming years
- Provide input to the following request from the COP: Best available techniques and best environmental practices relevant to the production, use, and lifecycle management (including products and articles containing chlorpyrifos, MCCPs and LC-PFCAs), such as identification, handling, separation and disposal technologies, and information on possible alternatives.
